Publication | Open Access
DNASE1L3 as a Prognostic Biomarker Associated with Immune Cell Infiltration in Cancer
39
Citations
43
References
2021
Year
DNASE1L3 has potential to serve as a prognostic biomarker in cancer of the breast, kidney, liver, stomach, lung adenocarcinoma and sarcoma. Down-regulation of DNASE1L3 may participate in immune escape via CCR7/CCL19 axis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1